rt-pa
Showing 1 - 14 of 14
Recombinant Tissue Plasminogen Activator Treated Chinese Acute
Completed
- Stroke
- rt-PA
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Dec 22, 2022
Elderly Acute Ischaemic Stroke (AIS) Patients
Completed
- Stroke
- rt-PA
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Dec 23, 2022
Alteplase in Elderly Acute Ischemic Stroke Patients During
Active, not recruiting
- Stroke
- rt-PA
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Jan 9, 2023
Stroke Trial in ShenYang (rt-PA, Argatroban)
Completed
- Stroke
- rt-PA
- Argatroban
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Feb 20, 2022
Argatroban, Rt-PA Trial in Shenyang (Argatroban combined with rt-PA, rt-PA)
Terminated
- Argatroban, Rt-PA
- Argatroban combined with rt-PA
- rt-PA
-
Shenyang, Liaoning, ChinaGeneral Hospital of Shenyang Military Region
Nov 12, 2018
Nervous System Disorders, Cerebral Artery Trial (rt-PA, tenecteplase)
Withdrawn
- Nervous System Disorders
- Cerebral Artery
- rt-PA
- tenecteplase
- (no location specified)
Jun 19, 2018
Hypertensive Intracerebral Hemorrhage Trial in Wuhan (YL-1 type of intracranial hematoma puncture needle, rt-PA)
Unknown status
- Hypertensive Intracerebral Hemorrhage
- YL-1 type of intracranial hematoma puncture needle
- rt-PA
-
Wuhan, Hubei, ChinaTongji Hospital
Jun 11, 2015
Ischemic Stroke, Stroke, Brain Infarction Trial in United States (Eptifibatide, rt-PA)
Malfunction; Catheter, Thrombosis, Mechanical Complication of Hemodialysis Catheter Trial in Sion (rt-PA (2mg/2mL) actilysis,
Unknown status
- Malfunction; Catheter
- +2 more
- rt-PA (2mg/2mL) actilysis
- rt-PA
-
Sion, Valais, SwitzerlandCentre Hospitalier du Centre du Valais (CHCVs)
Aug 20, 2012
Pulmonary Embolism, Thromboembolism Trial in China (rt-PA)
Completed
- Pulmonary Embolism
- Thromboembolism
- rt-PA
-
Beijing, Beijing, China
- +22 more
Oct 28, 2008